The Global Transcatheter Pacing System Market is projected to grow at a CAGR of 15.1% during the forecast period (2022 – 2030).  The growth of the global transcatheter pacing system market is driven by a rising number of patients with cardiac health problems. For patients with severe/symptomatic bradycardia, an arrhythmia characterised by an abnormally slow heart rate, traditional pacemakers have been the standard therapeutic option. The pacemaker technology has progressed significantly since 1958. The recently commercialised leadless or transcatheter pacemakers showcases a number of advantages. A transcatheter pacemaker is a small device that is placed (implanted) in the chest to help control the heartbeat. Implanting a pacemaker in the chest requires a surgical process. These devices, which are implanted wholly within the right ventricle, eliminate the need for transvenous pacing leads and pacemaker pockets, lowering the risk of infections and lead-related complications.

Key Market Participants:

  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • Other Market Participants

 

View Full Report Link: https://industryglobalnews24.com/global-transcatheter-pacing-system-market-to-witness-151-growth-during-2022-2029

Asia Pacific region is anticipated to witness fastest growth in the global transcatheter pacing system market over the forecast period. The massive investments in healthcare made by variety of international entities are expected to boost the transcatheter pacemaker systems market's growth potential in Asia Pacific. The demand for transcatheter pacemaker systems is projected to rise as cardiologists authorise their usage and worldwide health organisations demonstrate their use during treatments. Moreover, the transcatheter pacemakers implants have risen in the last few years, as the population with cardiovascular issues are rapidly increasing. In January 2022, Japan's Ministry of Health, Labor and Welfare provided approval to Medtronic plc for the sale and reimbursement of the Micra AV Transcatheter Pacing System (TPS), and the company is about to launch the product shortly. The approval has increased the number of eligible patients in Japan to receive the Micra TPS, for the treatment of patients with AV block. Such initiatives by the government and healthcare organizations are boosting the commercialization and usage of transcatheter pacing systems in Asia Pacific.

 

Global Transcatheter Pacing System Market

  • By Application
    • Atrial Fibrillation and Bradycardia
    • Atrioventricular Block
    • Sinus Node Dysfunction
    • Others
  • By End Users
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
      • Rest of North America
    • Europe
      • France
      • The UK
      • Spain
      • Germany
      • Italy
      • Nordic Countries
        • Denmark
        • Finland
        • Iceland
        • Sweden
        • Norway
      • Benelux Union
        • Belgium
        • The Netherlands
        • Luxembourg
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • New Zealand
      • Australia
      • South Korea
      • Southeast Asia
        • Indonesia
        • Thailand
        • Malaysia
        • Singapore
        • Rest of Southeast Asia
      • Rest of Asia Pacific
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • Egypt
      • Kuwait
      • South Africa
      • Rest of Middle East & Africa
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America

Contact Us:

Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91-740-024-2424 , US +1-510-420-1213
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com/